<DOC>
	<DOCNO>NCT00289250</DOCNO>
	<brief_summary>Treatment uncomplicated P.falciparum malaria sulfadoxine-pyrimethamine ( SP ) follow marked increase density gametocyte . To determine whether treatment SP enhance gametocyte carriage , randomize asymptomatic carrier P.falciparum receive SP alone , SP single dose artesunate , placebo , follow 56 day record gametocyte presence density .</brief_summary>
	<brief_title>Effect Antimalarial Treatment Gametocyte Carriage Asymptomatic P. Falciparum</brief_title>
	<detailed_description>Treatment P. falciparum malaria sulfadoxine-pyrimethamine ( SP ) follow sharp rise density gametocyte . Drug-induced release could enhance transmission resistant parasite would argue use SP , especially intermittent preventive treatment ( IPT ) . We randomize trial determine effect treatment SP gametocyte carriage . The trial three-arm open-label randomize trial . We randomize asymptomatic carrier P.falciparum receive antimalarial treatment placebo , record prevalence density gametocytes next 2 month . The trial conduct dry ( low malaria transmission ) season four rural village The Gambia . Adults child age 6 month asexual P.falciparum infection confirm free clinical symptom malaria 2-day screening period enrol randomized receive single dose SP , SP plus single dose artesunate ( SP+AS ) , placebo . The primary endpoint presence gametocytes 7 56 day treatment , duration density gametocytaemia 2 month measure area curve gametocyte density time .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Antimalarials</mesh_term>
	<criteria>P.falciparum parasitaemia 20/uL Resident one four study village Fever Any sign clinical malaria Pregnancy Weight &lt; 5kg History hypersensitivity study drug Treatment study drug last 4 week</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Gametocytes</keyword>
	<keyword>Asymptomatic carrier</keyword>
</DOC>